The evaluation of surrogate endpoints

Both humanitarian and commercial considerations have spurred intensive search for methods to reduce the time and cost required to develop new therapies. The identification and use of surrogate endpoints, i.e., measures that can replace or supplement other endpoints in evaluations of experimental tre...

Fuld beskrivelse

Enregistré dans:
Bibliografiske detaljer
Hovedforfatter: Burzykowski, Tomasz
Andre forfattere: Molenberghs, Geert (Directeur de la publication), Buyse, Marc (Directeur de la publication)
Format: Livre numérique
Sprog:Anglais
Udgivet: New York, NY : Springer New York 2005.
Cham : Springer Nature
Serier:Statistics for Biology and Health
Online adgang:Accès sur la plateforme de l'éditeur
Accès sur la plateforme Istex
Accès Université d'Orléans
Accès INSA CVL
Kommentar: Archives Springer e-books (Licence nationale)
Archives Springer e-books (Licence nationale)
Autres localisations: Voir dans le Sudoc
Edition sous un autre format:• The Evaluation of Surrogate Endpoints, Texte imprimé, 9780387500867
• The Evaluation of Surrogate Endpoints, Texte imprimé, 9781441919069
• The Evaluation of Surrogate Endpoints, Texte imprimé, 9780387202778
Indholdsfortegnelse:
  • Setting the Scene
  • Regulatory Aspects in Using Surrogate Markers in Clinical Trials
  • Notation and Motivating Studies
  • The History of Surrogate Endpoint Validation
  • Validation Using Single-trial Data: Mixed Binary and Continuous Outcomes
  • A Meta-analytic Validation Framework for Continuous Outcomes
  • The Choice of Units
  • Extensions of the Meta-analytic Approach to Surrogate Endpoints
  • Meta-analytic Validation with Binary Outcomes
  • Validation in the Case of Two Failure-time Endpoints
  • An Ordinal Surrogate for a Survival True Endpoint
  • A Combination of Longitudinal and Survival Endpoints
  • Repeated Measures and Surrogate Endpoint Validation
  • Bayesian Evaluation of Surrogate Endpoints
  • Surrogate Marker Validation in Mental Health
  • The Evaluation of Surrogate Endpoints in Practice: Experience in HIV
  • An Alternative Measure for Meta-analytic Surrogate Endpoint Validation
  • Discussion: Surrogate Endpoint Definition and Evaluation
  • The Promise and Peril of Surrogate Endpoints in Cancer Research.